SG11202004631RA - New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7 - Google Patents

New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7

Info

Publication number
SG11202004631RA
SG11202004631RA SG11202004631RA SG11202004631RA SG11202004631RA SG 11202004631R A SG11202004631R A SG 11202004631RA SG 11202004631R A SG11202004631R A SG 11202004631RA SG 11202004631R A SG11202004631R A SG 11202004631RA SG 11202004631R A SG11202004631R A SG 11202004631RA
Authority
SG
Singapore
Prior art keywords
inhibitors
specific protease
ubiquitin specific
piperidinyl derivatives
new piperidinyl
Prior art date
Application number
SG11202004631RA
Inventor
András Kotschy
Csaba Wéber
Attila Vasas
Árpád Kiss
Balázs Molnár
Ágnes Strofek
Vilibald Kun
James Brooke Murray
Alba Macias
Elodie Lewkowicz
Maïa Chanrion
Lisa Ivanschitz
Olivier Geneste
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of SG11202004631RA publication Critical patent/SG11202004631RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
SG11202004631RA 2017-11-29 2018-11-28 New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7 SG11202004631RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1761338 2017-11-29
PCT/EP2018/082766 WO2019105963A1 (en) 2017-11-29 2018-11-28 New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7

Publications (1)

Publication Number Publication Date
SG11202004631RA true SG11202004631RA (en) 2020-06-29

Family

ID=62091951

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004631RA SG11202004631RA (en) 2017-11-29 2018-11-28 New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7

Country Status (17)

Country Link
US (1) US11332472B2 (en)
EP (1) EP3717482A1 (en)
JP (1) JP2021504388A (en)
KR (1) KR20200094176A (en)
CN (1) CN111542524A (en)
AR (1) AR113846A1 (en)
AU (1) AU2018377976A1 (en)
BR (1) BR112020010547A2 (en)
CA (1) CA3083320C (en)
EA (1) EA202091260A1 (en)
IL (1) IL274737A (en)
MA (1) MA51202A (en)
MX (1) MX2020005500A (en)
RU (1) RU2020120043A (en)
SG (1) SG11202004631RA (en)
TW (1) TW201925202A (en)
WO (1) WO2019105963A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113087724B (en) * 2020-01-08 2024-01-19 四川科伦博泰生物医药股份有限公司 Isothiazolopyrimidinone compounds, pharmaceutical compositions containing the same and uses thereof
CN113087718B (en) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 Thienopyrimidinone compounds and medical application thereof
CN112047933B (en) * 2020-10-15 2022-06-14 郑州大学 Quinazolinone USP7 inhibitor and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI698436B (en) * 2014-12-30 2020-07-11 美商佛瑪治療公司 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
MA41291A (en) 2014-12-30 2017-11-07 Forma Therapeutics Inc PYRROLOTRIAZINONE AND IMIDAZOTRIAZINONE DERIVATIVES AS UBIQUE-SPECIFIC PROTEASE INHIBITORS No. 7 (USP7) FOR THE TREATMENT OF CANCER
FR3052452B1 (en) * 2016-06-10 2018-06-22 Les Laboratoires Servier NOVEL PIPERIDINYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Also Published As

Publication number Publication date
BR112020010547A2 (en) 2020-10-27
US11332472B2 (en) 2022-05-17
AU2018377976A1 (en) 2020-06-04
EP3717482A1 (en) 2020-10-07
MA51202A (en) 2020-10-07
TW201925202A (en) 2019-07-01
US20200407363A1 (en) 2020-12-31
RU2020120043A (en) 2021-12-29
WO2019105963A1 (en) 2019-06-06
CA3083320A1 (en) 2019-06-06
KR20200094176A (en) 2020-08-06
CN111542524A (en) 2020-08-14
JP2021504388A (en) 2021-02-15
AR113846A1 (en) 2020-06-17
CA3083320C (en) 2022-08-16
IL274737A (en) 2020-07-30
EA202091260A1 (en) 2020-09-07
MX2020005500A (en) 2020-08-31

Similar Documents

Publication Publication Date Title
IL266146A (en) Piperidine derivatives as inhibitors of ubiquitin specific protease
IL282103A (en) Purinones as ubiquitin-specific protease 1 inhibitors
ZA201807865B (en) Formulations of an lsd1 inhibitor
HK1249905A1 (en) Heterocyclic compounds as lsd1 inhibitors
HK1248222A1 (en) Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
SI3464272T1 (en) Novel heterocyclic derivatives useful as shp2 inhibitors
EP3268367B8 (en) Carboxamide inhibitors of irak4 activity
ZA201701799B (en) Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
IL273842A (en) 1-benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as hiv protease inhibitors
HK1246164A1 (en) Substituted pyrazole compounds as serine protease inhibitors
HK1251566A1 (en) Piperidine derivatives as hdac1/2 inhibitors
IL274737A (en) New piperidinyl derivatives as inhibitors of ubiquitin specific protease 7
IL269695A (en) Compounds useful as inhibitors of alcat 1
ZA202004909B (en) 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (usp19)
IL274036A (en) Novel pyrazolo-pyrrolo-pyrimidine-dione derivatives as p2x3 inhibitors
EP3097084A4 (en) New kallikrein 7 inhibitors
SI3638686T1 (en) Peptidyl ketoamides as inhibitors of rohomboid proteases
GB201715589D0 (en) Protease inhibitors
EP3463374A4 (en) A long acting pharmaceutical composition of protease inhibitor